Olivier Lortholary is Professor of Medicine at Paris Descartes University and holds multiple significant positions in the field of medical mycology and infectious diseases. He serves as Deputy Director of the French National Reference Center for Invasive Mycoses and Antifungals, and is Head of the Necker-Pasteur Center for Infectious Diseases and Tropical Medicine at Necker Hospital in Paris. His work is closely associated with the Institut Pasteur in Paris, France, where he is actively involved in research and teaching initiatives. Dr. Lortholary's educational background includes an M.D. from the Paris 6 School of Medicine and a Ph.D. from Paris 7 University. His extensive academic career has positioned him as a leading expert in medical mycology, with particular focus on fungal infections in immunocompromised patients. His research primarily centers on translational aspects of medical mycology, with special emphasis on Cryptococcus neoformans and cryptococcal meningitis, which represents the leading opportunistic fungal infection in advanced HIV-infected patients. He also investigates new immune deficiencies that predispose individuals to invasive fungal infections, develops diagnostic and therapeutic innovations for these conditions, and conducts clinical and microbiological studies of central nervous system infections and emerging infectious diseases. Dr. Lortholary has made substantial contributions to the field, with over 590 published papers, including more than 12 invited contributions to prestigious journals such as Clinical Infectious Diseases and Lancet Infectious Diseases. His research spans epidemiology of fungal infections, antifungal susceptibility testing, and clinical management approaches across various patient populations. He plays a significant role in shaping clinical guidelines as a member of various international expert panels, including the Infectious Diseases Society of America (for cryptococcosis management), the American Society of Transplantation (for donor-derived fungal infections), and ESCMID (for Candida and other fungal infections). Additionally, he serves as the French representative on the EUCAST Antifungal Susceptibility Testing Committee. As an educator, Dr. Lortholary co-directs the Medical Mycology course at the Pasteur Institute and has developed a MOOC (Massive Open Online Course) on Medical Mycology available through FUN-MOOC, reaching a global audience of healthcare professionals and researchers.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۴۶ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
Alastair F. Donaldson is a Professor and Director of Research in the Department of Computing at Imperial College London, where he leads the FastPL research group. His work bridges formal methods, software testing, and programming languages, with a focus on enhancing the reliability of high-performance and parallel software systems. He has held key roles including Director of Research (since 2023) and previously served as Lecturer (2011–2014), Senior Lecturer (2014–2017), and Reader (2017–2020) before being promoted to Professor in 2020. His research interests include formal verification, compiler testing, GPU programming, concurrency, and fuzzing. He has made significant contributions to the verification of GPU kernels, metamorphic testing of graphics drivers, and the development of tools like GPUVerify and GraphicsFuzz. His work combines theoretical rigor with practical impact, demonstrated by the acquisition of his startup GraphicsFuzz by Google in 2018 and his subsequent roles as Senior Software Engineer and Visiting Researcher at Google. His recent publications reflect a sustained focus on compiler and system reliability, with trends in fuzzing, formal specification, and automated testing of complex systems such as WebGPU, CXL cache coherence, and large language models for code generation. His work increasingly integrates empirical validation with formal techniques to uncover subtle bugs in real-world systems. Scientific awards and recognitions include: 2017 BCS Roger Needham Award EPSRC Early Career Fellowship Fellow of the British Computer Society Best Paper awards at EuroSys 2024, MET 2021, IISWC 2019, IWOCL 2019, and ICST 2016 Best Industry Paper at ICST 2024 ACM SIGSOFT Distinguished Paper at ISSTA 2023 ACM SIGPLAN Most Influential OOPSLA Paper Award (2012 paper), awarded in 2022 Best Student Paper at PPoPP 2014 He has advised numerous PhD students and leads a vibrant research group. He has secured significant research funding and collaborates extensively with industry and academia. His service includes leadership roles such as General Chair of PLDI 2020, PC Chair of ECOOP 2019, and Steering Committee Chair of PLDI (2022–2025). He also serves on the advisory board of PACM-PL and on program committees for top venues including POPL, OOPSLA, PLDI, ICSE, and ISSTA. He leads the FastPL research group, which focuses on the design and implementation of programming tools and techniques for reliable software. The group conducts cutting-edge research in compiler testing, formal methods, and high-performance systems, fostering collaboration across academia and industry.
- Software Evolution
- Software Libraries
- APIs
- +۵ مورد دیگر
Thomas Degueule is a CNRS researcher in the Software Engineering group at LaBRI (Bordeaux, France). His research focuses on software evolution , modularity , and comprehension , with a particular emphasis on software libraries , APIs , software ecosystems , and domain-specific languages (DSLs) . Prior to his current role, he worked as a postdoctoral researcher at CWI (Amsterdam) and earned his PhD at IRISA (Rennes, France). Research Themes : Software evolution, API analysis, dependency management, empirical software engineering, DSL engineering Projects : ANR JCJC ALIEN (PI), H2020 CROSSMINER (WP leader), ALE (associate member), LEOC Clarity (member), ANR INS GEMOC (member), ITEA2 MERgE (member) Software Tools : Roseau, Maracas, BreakBot, Melange, Eclipse GEMOC Studio, K3, Alex, Scava His recent publications highlight trends in API breaking changes , dependency evolution , DSL interoperability , and automated software analysis (see articles list for details). He also contributes to software education through tools like MOON and Immediate Feedback for Jupyter Notebooks. Thomas has supervised PhD students including Gustave Monce (University of Bordeaux), Lina Ochoa (now assistant professor at Eindhoven University), Corentin Latappy (post-doc at University of Bordeaux), and Christophe Casseau (lecturer at University of Bordeaux). He actively participates in academic service, serving on program committees for conferences such as ICSE , ASE , ICSME , ISSTA , and SLE , and organizing workshops like SLEBoK and MLE 2021 .
Lucy Gloverمشاهده پروفایل
پژوهشگر
Lucy Glover is a Researcher and Group Leader of the Trypanosome Molecular Biology laboratory at the Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France. She joined the institute in March 2016 as a G5 group leader, focusing on the molecular mechanisms of antigenic variation and DNA repair in Trypanosoma brucei , the causative agent of Human African Trypanosomiasis. Her research integrates molecular, biochemical, and high-throughput approaches to study DNA recombination and immune evasion. Institut Pasteur, Paris (2016–Present) PhD, London School of Hygiene and Tropical Medicine Her research interests center on antigenic variation , DNA repair , and homologous recombination in trypanosomes. She investigates how DNA double-strand breaks influence variant surface glycoprotein (VSG) switching, a critical process for parasite survival in the host. Her lab uses advanced techniques such as RIT-seq, phosphoproteomics, and CRISPR-based tools to dissect these mechanisms at the molecular level. The recent publications of Lucy Glover span molecular parasitology, DNA damage response, and diagnostic development. Key themes include the role of the MRN complex in DNA repair, phosphoproteomic profiling of DNA damage responses, and the design of CRISPR-based diagnostics for HAT. Her work reveals how chromosomal context influences repair pathways and antigenic variation, contributing to a deeper understanding of parasite biology. While no formal scientific awards are listed in the provided text, her contributions are evident through high-impact publications and leadership in collaborative research projects. Lucy Glover advises several PhD and postdoctoral researchers, including Emilia MacLaughlin, Nuria Sima Teruel, and Alix Thivolle. Her lab is supported by institutional initiatives such as LabEx IBEID and transversal drug discovery programs. She collaborates with teams working on host-pathogen interactions, genomics, and infectious disease epidemiology. Her laboratory is part of the Department of Parasites and Insect Vectors and participates in departmental retreats and seminars. The team includes post-docs, research engineers, and administrative staff, reflecting a collaborative and interdisciplinary research environment focused on combating neglected tropical diseases.
Mathias Payerمشاهده پروفایل
دانشیار
- Software Security
- System Security
- Fuzzing
- +۵ مورد دیگر
Mathias Payer is an associate professor at EPFL's School of Computer and Communication Sciences (IC), leading the HexHive research group since 2018. He focuses on strengthening software and system security through fuzzing, vulnerability mitigation, and compiler-based approaches. His work includes open-source prototypes and contributions to embedded systems, IoT security, and trusted execution environments. Education: PhD in Computer Science (Dr. sc. ETH) from ETH Zurich (2012), postdoctoral researcher at UC Berkeley (2012–2014), and assistant professor at Purdue University (2014–2018). Tenured at EPFL since 2021. Research Interests: Fuzzing frameworks, memory safety, vulnerability analysis, compiler optimizations for security, and firmware security. Projects include Enclosure , HexType , and DP3T (decentralized contact tracing). Awards: Multiple best/distinguished paper awards at top venues (e.g., Usenix Security, NDSS, RAID). Co-founded the EPFL polygl0ts and Purdue b01lers CTF teams to foster cybersecurity innovation. Labs/Teams: HexHive group, CTF initiatives, and collaborations with industry (e.g., Intel SGX, Android security).
R.-A. Lavergneمشاهده پروفایل
استادیار
R.-A. Lavergne serves as an Assistant Professor and Hospital Practitioner at the University of Nantes, specializing in medical mycology with a focus on antifungal resistance mechanisms and environmental drivers of resistance. Their work bridges clinical practice and environmental microbiology through the One Health framework, investigating azole resistance in Aspergillus species and diagnostic innovations for fungal pathogens. Educational background includes a PhD on Aspergillus fumigatus resistance mechanisms defended at the University of Nantes in July 2018. Advanced training encompasses molecular diagnostics, antifungal susceptibility testing, and environmental sampling methodologies. Research centers on azole resistance evolution in Aspergillus , particularly TR-mutation pathways (TR34/L98H, TR46/Y121F/T289A), and agricultural fungicide impacts on clinical resistance. Key projects examine sterol biosynthesis alterations under drug pressure, environmental reservoirs in crop fields, and novel antifungal compounds like CIN-102. Diagnostic work includes Mucorales DNA detection in serum and MALDI-TOF optimization for cryptic Candida species. Recent publications reveal three dominant research axes: (1) Environmental origins of resistance (Colombian crop studies); (2) Molecular mechanisms of TR-mutation-mediated resistance; (3) Diagnostic innovations for mucormycosis and rare fungal pathogens. This integrated approach spans genomic, biochemical, and epidemiological methodologies. Active involvement in national research initiatives includes ANR TEILEISH, ANR AspergillusOne-Health, ANR Chair INSERM COMBINE, ANR OTARI, ANR AspergIs, ANR FungiSol, and ANR INTERLUDE. Collaborative networks span French cystic fibrosis centers, transplant units, and international agricultural health projects. As part of the Department of Medical Mycology and Parasitology, Dr. Lavergne contributes to clinical diagnostics for immunocompromised patients while leading environmental resistance surveillance. The research group maintains active collaborations with Prof. Le Pape's team on resistance mechanisms and Prof. Morio's diagnostics unit.
Katy JEANNOTمشاهده پروفایل
استاد بالینی
Katy JEANNOT is a Clinical Professor affiliated with the University of Bourgogne Franche-Comté and the CHU Besançon Hospital. Her research focuses on antibiotic resistance mechanisms in Pseudomonas aeruginosa and Acinetobacter baumannii, including efflux pumps, genetic determinants of resistance, and adaptations to antimicrobial peptides. She investigates clinical isolates from cystic fibrosis patients, analyzing their phenotypic and genotypic evolution. Her work spans epidemiological studies of antibiotic resistance, such as the 2023–24 Mycoplasma pneumoniae outbreak in France, and evaluates new antimicrobial agents like cefiderocol and murepavadin. She collaborates on projects involving rapid diagnostic tests for carbapenemases and genomic studies of high-risk bacterial clones. Key research areas include multidrug resistance mechanisms, envelope stress responses, and the development of novel antimicrobial strategies. She has contributed to clinical trials assessing compassionate use of antibiotics and has authored/co-authored over 80 peer-reviewed articles, emphasizing global antibiotic resistance surveillance and molecular epidemiology. Affiliations: CHU Besançon, UMR 6249 Chrono-Environnement, University of Bourgogne Franche-Comté Labs/Teams: Involved in multidisciplinary teams studying microbial pathogenesis and antimicrobial resistance.
Pierre Lafayeمشاهده پروفایل
پژوهشگر
- Antibody Engineering
- Nanobodies (VHH)
- Immunotherapy
- +۱۳ مورد دیگر
Pierre Lafaye is the Head of the Antibody Engineering Platform at the Institut Pasteur, a leading institution in biological and medical research. His work is situated within the Technology Department, where he leads a core facility focused on the development and application of VHH (nanobody) technologies. The platform supports a wide range of academic and translational research projects, leveraging the unique properties of nanobodies such as small size, high stability, tissue penetration, and blood-brain barrier crossing ability. Research Interests: Dr. Lafaye’s research spans multiple domains, including cancer immunotherapy (e.g., targeting ILT4 as an immune checkpoint), neurodegenerative diseases (e.g., imaging Alzheimer’s plaques and tangles), infectious diseases (e.g., SARS-CoV-2 diagnostics and therapeutics), and antimicrobial resistance (e.g., targeting β-lactamases). His expertise lies in phage display, protein engineering, and in vivo molecular imaging. He has pioneered the use of dimeric VHHs for sensitive immunoassays and targeted diagnostics. Recent Publication Trends: His recent publications (2021–2024) reflect a strong emphasis on structural biology (using cryo-EM), viral entry mechanisms (especially coronaviruses), and the therapeutic and diagnostic application of nanobodies. Collaborative, high-impact studies in journals like Nature , Cell , and Nature Communications highlight his role in cutting-edge interdisciplinary research. Scientific Awards: While no specific awards are listed in the provided text, his leadership in IBiSA-certified core facilities and participation in major networks like EuroMabNet, Core For Life (CFL), and CTLS reflect recognition of his technical and scientific contributions. Advising and Grants: Dr. Lafaye has supervised multiple PhD students and postdoctoral researchers, indicating an active mentoring role. He leads several funded projects, including the ongoing CORONABODIES and Advances in Cancer Immunotherapy projects, as well as completed initiatives like ChagasDiag and VenoMATIcs. These projects involve collaborations across international Pasteur Institutes and academic partners. Labs and Teams: As head of the Antibody Engineering Platform, he oversees a multidisciplinary team comprising research engineers, technicians, postdocs, and PhD students. The facility is part of broader transversal initiatives at the Institut Pasteur, including those in brain connectivity, cancer, and emerging infectious diseases.
Didier Ménard is a Full Professor at the University of Strasbourg and Director of the Institute of Parasitology and Tropical Diseases (UR7292). Since 2023, he serves as a visiting researcher in the Malaria Parasite Biology and Vaccines Unit at the Pasteur Institute, headed by Chetan Chitnis. Previously, from 2017 to 2021, he led the Malaria Genetics and Resistance Group and later the Malaria Genetics and Resistance Unit at the Pasteur Institute Paris. Dr. Ménard's research focuses on antimalarial drug resistance in both Plasmodium falciparum and Plasmodium vivax parasites. His work spans molecular epidemiology, genetics of resistance mechanisms, and development of surveillance tools for drug-resistant malaria. He has conducted extensive field research in Africa (Central African Republic, Madagascar) and Southeast Asia (Cambodia), contributing significantly to our understanding of malaria transmission dynamics and resistance patterns. His research has revealed critical insights into P. vivax infection mechanisms in Duffy-negative populations and identified key molecular markers of artemisinin and piperaquine resistance in P. falciparum . Most notably, his team demonstrated that mutations in the K13 propeller domain and amplifications of plasmepsin II and III genes are major determinants of artemisinin and piperaquine resistance, respectively. Analysis of his recent publications (2023-2025) reveals a strong focus on emerging drug resistance patterns, particularly artemisinin-resistant malaria in Africa, molecular mechanisms of parasite invasion, and genomic epidemiology of P. vivax in sub-Saharan Africa. His work increasingly addresses the dual challenges of diagnostic limitations (HRP2-negative malaria) and treatment failures in malaria-endemic regions. Dr. Ménard has led several significant research projects including IMPRIMA (Implementing Primaquine Single Low Dose in Africa), TipTop (monitoring sulfadoxine-pyrimethamine resistance), development of new biomarkers for malaria detection, and SaMARA (Surveillance and Monitoring of Antimalarial Resistance in Africa). His laboratory utilizes advanced genomic and molecular techniques to characterize drug-resistant parasite populations.
Guilhem Janbonمشاهده پروفایل
پژوهشگر
- Mycology
- Fungal Pathogenesis
- RNA Biology
- +۸ مورد دیگر
Guilhem Janbon is a Researcher and Head of the Laboratory of RNA Biology of Fungal Pathogens within the Mycology Department at the Institut Pasteur in Paris, France. He leads a multidisciplinary research team focused on understanding the molecular biology of human fungal pathogens, particularly Cryptococcus neoformans . His work bridges fundamental research on gene expression with translational applications in medical mycology. His primary research interests include: Transcriptome structure and plasticity in fungi Regulation of gene expression via alternative splicing and transcription start site (TSS) usage The role of long non-coding RNAs (lncRNAs) in fungal biology The biogenesis and function of fungal extracellular vesicles (EVs) Host-pathogen interactions and fungal virulence mechanisms His recent publications reveal a strong trend towards understanding dynamic gene regulation in response to environmental stress and its impact on antifungal resistance and virulence. A significant portion of his work explores the potential of fungal extracellular vesicles as both virulence factors and novel vaccine platforms, indicating a forward-looking approach to therapeutic development. Dr. Janbon actively mentors a team of young scientists, including PhD students and post-doctoral researchers, fostering the next generation of mycologists. He leads several research projects funded by the Institut Pasteur, such as those investigating lncRNAs and intron-dependent gene regulation in Cryptococcus . He is also involved in collaborative research, notably as a co-leader of the Pasteur International Unit on Fungal Extracellular Vesicles with partners in the UK and Brazil, highlighting his role in international scientific networks.
Jean-Louis is a Professor at the University of Lorraine, affiliated with the Department of Mathematics, Computer Science, and Mechanics under the Analysis and Number Theory team. Current position: Professor Institution: University of Lorraine Department: Mathematics, Computer Science, and Mechanics Research team: Analysis and Number Theory His research spans mathematical analysis applied to biological systems, with a focus on metabolic disorders , genetic variations , and multi-omics modeling . Key areas include vitamin B12 deficiency pathophysiology, microbiome dynamics, and systems medicine approaches for inherited diseases. Computational modeling of metabolic pathways Epigenetic signatures in disease states Integration of genomics with clinical outcomes Mathematical frameworks for personalized medicine Biostatistical analysis of population health data Jean-Louis has published extensively in translational medicine journals , addressing topics like sepsis biomarkers, drug hypersensitivity, and dietary toxicants. His work bridges mathematical rigor with clinical applications in metabolic and genetic disorders.
Jeff Offutt is a Professor and Chair of the Department of Computer Science at the University at Albany, part of the College of Nanotechnology, Software, & Engineering. Previously, he was a Full Professor with Tenure in Software Engineering at George Mason University, where he led the MS in Software Engineering program and developed numerous courses in software testing, web engineering, and software analysis. His research has significantly influenced both academia and industry in software testing and engineering education. His research interests span software testing, mutation testing, model-based testing, automatic test data generation, web application testing, and software engineering education. He has pioneered techniques such as bypass testing and model-based testing, with applications embedded in tools like Selenium. His work emphasizes practical, impactful research—what he calls "science fiction"—with a clear path to real-world use by software engineers. His recent publications reflect a strong trend in cost-effective mutation testing, model-based testing strategies, educational innovations like self-paced learning models (e.g., SPARC), and security aspects of web applications. The keywords across his work include software testing, empirical studies, automation, and education, with subfields such as fault localization, test oracles, input partitioning, and scalable pedagogy. John Toups Presidential Medal for Excellence in Teaching (2020) George Mason University Faculty Member of the Year (2020) Virginia Outstanding Faculty Award (2019) George Mason Teaching Excellence Award (2013) 10-year Most Influential Paper Award, MODELS 2020 Best Paper Award, ICST 2021 Most Influential Paper, ISSRE (2019) Jeff Offutt has advised numerous students and collaborated internationally, including at Swedish universities. He has led major educational initiatives such as the NSF-funded SPARC project, aimed at improving scalability and diversity in introductory CS courses. He has also been actively involved in curriculum development, including co-authoring IEEE/ACM guidelines for software engineering programs. His leadership extends to founding and chairing major conferences like IEEE ICST and serving as Editor-in-Chief of Software Testing, Verification and Reliability . He leads research projects on smart test automation, minimal mutation, and K–5 computer science integration. His work has resulted in widely used tools including muJava, Mothra, and SpecTest. He frequently gives keynote talks on testing, education, and research methodology, and is known for his popular talk "How to Get Your Paper Rejected."
Dr. Ourliac-Garnier is an Associate Professor conducting cutting-edge research in antifungal drug discovery and medical mycology, with recent publications spanning 2018–2025. Her work bridges medicinal chemistry and fungal pathogenesis, focusing on designing novel antifungal agents and elucidating resistance mechanisms in clinically significant pathogens. Her primary research domains include: Antifungal Drug Discovery (scaffold modification of itraconazole, triazoles, and natural products) Medical Mycology (fungal sterol biosynthesis, resistance in Candida and Aspergillus ) One Health Perspectives (zoonotic fungal pathogens like Diutina catenulata ) Medicinal Chemistry (kinase inhibitors, hybrid molecules, structure-activity optimization) Analysis of her 14 recent publications reveals consistent emphasis on chemical synthesis of antifungal candidates coupled with rigorous biological evaluation. Key trends include targeting sterol biosynthesis pathways to overcome azole resistance, developing dual-action kinase inhibitors, and applying analytical techniques like GC-MS for fungal lipidomics. Her work frequently addresses drug resistance through genome editing and mechanistic studies. Dr. Ourliac-Garnier actively participates in major collaborative projects funded by: French National Research Agency (ANR TEILEISH, ANR AspergillusOne-Health, ANR FungiSol, ANR INTERLUDE) INSERM Chair COMBINE EUniWell IMiTI consortium CAPES-COFECUB international collaborations (Me1009/23, Me1080/25) She operates within a multidisciplinary team encompassing the Department of Medical Mycology and Parasitology, Department of Medicinal Chemistry, and Department of Bacterial Resistances. Her research directly supports three core themes: One Health approaches to fungal persistence, immunity-microbiota interactions, and novel therapeutic target identification.
Saaid Safieddine is a Permanent Researcher (DR2 CNRS) at the Institut Pasteur in Paris, where he co-leads the Auditory Cognition and Communication team. His research focuses on developing translational gene therapies for hereditary and acquired hearing loss, particularly targeting genetic deafness such as DFNB9 caused by otoferlin mutations. He works within a multidisciplinary team that includes engineers, researchers, and ENT surgeons, aiming to bridge molecular discoveries with clinical applications through robotic delivery systems. His primary research interests include: Molecular physiology of hearing and auditory synapses Gene therapy for inner ear abnormalities Adeno-associated virus (AAV) vector design and tropism Otoferlin gene expression and regulation Translational neuroscience and preclinical modeling Cell-specific targeting in the inner ear His recent publications (2019–2025) demonstrate a consistent and impactful research trajectory in gene therapy for deafness. The work shows a progression from foundational studies on synaptic mechanisms to advanced preclinical models and clinical translation. Key themes include the development of dual-AAV systems for otoferlin delivery, in vivo tropism studies across developmental stages, restoration of auditory processing, and expanding therapeutic time windows in Usher syndrome models. His research increasingly integrates developmental biology, viral engineering, and behavioral neuroscience to address the full spectrum of hearing restoration. Saaid Safieddine has not been noted to have received specific scientific awards in the provided texts. However, his leadership in high-impact projects such as the ANR "Robocop" initiative and collaborations with clinical centers (Pitié-Salpêtrière and Necker Hospitals) indicate significant research funding and institutional support. He supervises PhD students and postdoctoral researchers, contributing to the training of next-generation scientists in auditory neuroscience and gene therapy. He is involved in multidisciplinary research teams and collaborative projects that integrate: The Auditory Cognition and Communication team at Institut Pasteur The RobOtol robotic surgery project for otological interventions Clinical ENT departments at Pitié-Salpêtrière and Necker University Hospitals The Hearing Institute for translational development ANR-funded projects like "Robocop" for active cochlear implants
Tyler Sorensenمشاهده پروفایل
استادیار
- Concurrency
- Heterogeneous Systems
- Compilers
- +۴ مورد دیگر
Tyler Sorensen is an Assistant Professor at the University of California, Santa Cruz in the Department of Computer Science and Engineering. He is currently on leave working with the RiSE group at Microsoft Research . His research focuses on concurrency programming, heterogeneous systems (GPUs, accelerators), compilers , and memory consistency models . PhD in Computer Science, Imperial College London (2018) MS in Computer Science, University of Utah (2014) BSc in Computer Science, University of Utah (2012) His work explores programming models for correctness and efficiency on emerging architectures, particularly GPGPU programming. He contributes to standards evolution with the Khronos Group and has developed testing frameworks for GPU memory consistency. His research has significant implications for parallel programming and GPU architecture design . His recent publications analyze GPU memory behavior, concurrency models, and performance portability across different architectures. Key trends include formal verification of memory models, empirical testing frameworks, and performance optimization for heterogeneous systems. Scientific Awards & Recognitions: ISSTA'23 Distinguished Artifact Award ASPLOS'23 Distinguished Paper & Artifact Awards IISWC'19 Best Paper Award PLDI'18 Distinguished Paper Award FSE'17 Distinguished Paper Award ISPASS'20 Best Paper Nomination Tyler advises a diverse group of students working on GPU programming, memory models, and heterogeneous systems. He has served on numerous program committees including ASPLOS 2024, PLDI 2024, and IWOCL 2019, and has been program co-chair for PLDI 2021 and 2022 Student Research Competition.